Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Int J Cancer ; 92(4): 551-4, 2001 May 15.
Article in English | MEDLINE | ID: mdl-11304690

ABSTRACT

We have previously reported that losses of genomic material from the long arm of chromosome 18 are frequent in atypical and anaplastic meningiomas but rare in benign meningiomas. In the present study, we have investigated a series of 37 meningiomas for mutation and expression of 4 tumor suppressor genes (MADH2, MADH4, APM-1 and DCC) located at 18q21. Comparative genomic hybridization or loss of heterozygosity analysis showed losses on chromosome 18 that included sequences from 18q21 in 15 of 37 tumors. Mutation analysis of APM-1 revealed a missense mutation (c. 1819G>A: G607S) in 1 atypical meningioma. None of the tumors showed mutations of MADH2 and MADH4 or loss of detectable transcripts from MADH2, MADH4, APM-1 and DCC. In contrast to human brain tissue, normal leptomeninges and meningiomas showed preferential expression of a DCC splice variant lacking 60 base pairs from exon 17. Taken together, our data do not support a significant role for MADH2, MADH4, APM-1 and DCC alterations in the pathogenesis of meningiomas. The targeted gene that is inactivated in most meningiomas with 18q losses remains to be identified.


Subject(s)
Brain Neoplasms/genetics , Cell Adhesion Molecules/genetics , Chromosome Aberrations , Chromosomes, Human, Pair 18/genetics , DNA-Binding Proteins/genetics , Intercellular Signaling Peptides and Proteins , Meningioma/genetics , Proteins/genetics , Trans-Activators/genetics , Tumor Suppressor Proteins , Adiponectin , Adolescent , Adult , Aged , Alleles , Alternative Splicing , Brain/metabolism , Child , DCC Receptor , DNA Mutational Analysis , Exons , Female , Humans , Loss of Heterozygosity , Male , Meninges/metabolism , Middle Aged , Mutation , Mutation, Missense , Nucleic Acid Hybridization , Polymorphism, Single-Stranded Conformational , RNA, Messenger/metabolism , Receptors, Cell Surface , Reverse Transcriptase Polymerase Chain Reaction , Smad2 Protein , Smad4 Protein
2.
Virchows Arch ; 436(5): 487-93, 2000 May.
Article in English | MEDLINE | ID: mdl-10881743

ABSTRACT

Malignant melanomas frequently show loss of alleles on the long arm of chromosome 10. The PTEN (MMAC1) gene has been identified as a tumour suppressor gene at 10q23.3 that is mutated in various types of advanced human cancers. We have investigated a series of 40 sporadic melanomas from 37 patients (15 primary cutaneous melanomas and 25 melanoma metastases) for allelic losses on chromosome 10, as well as for deletion and mutation of the PTEN gene. Microsatellite analysis revealed loss of heterozygosity at loci located on 10q in tumours from 15 of 34 patients investigated (44%). Somatic PTEN mutations were identified in melanomas from 4 of 37 patients (11%), all of whom had metastatic disease. In two of these patients, the tumours had additionally lost one PTEN allele, indicating complete loss of wild-type PTEN in the tumour cells. Our findings corroborate that loss of heterozygosity on chromosome 10 is a frequent aberration in malignant melanomas and implicate PTEN as a tumour suppressor gene inactivated by somatic mutation in a fraction of these tumours.


Subject(s)
Chromosomes, Human, Pair 10/genetics , Genes, Tumor Suppressor/genetics , Loss of Heterozygosity , Melanoma/genetics , Mutation , Phosphoric Monoester Hydrolases/genetics , Skin Neoplasms/genetics , Tumor Suppressor Proteins , Adult , Aged , Aged, 80 and over , DNA, Neoplasm/analysis , Female , Humans , Male , Melanoma/secondary , Microsatellite Repeats , Middle Aged , PTEN Phosphohydrolase , RNA, Neoplasm/analysis , Reverse Transcriptase Polymerase Chain Reaction , Skin Neoplasms/pathology
3.
Brain Pathol ; 10(1): 73-84, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10668897

ABSTRACT

We performed a genome wide screening for genomic alterations on a series of 19 sporadic primary central nervous system lymphomas (PCNSL) of the diffuse large B-cell type by comparative genomic hybridization (CGH). The tumors were additionally analyzed for amplification and rearrangement of the BCL2 gene at 18q21 as well as for mutation of the recently cloned BCL10 gene at 1p22. Eighteen tumors showed genomic imbalances on CGH analysis. On average, 2.1 losses and 4.7 gains were detected per tumor. The chromosome arm most frequently affected by losses of genomic material was 6q (47%) with a commonly deleted region mapping to 6q21-q22. The most frequent gains involved chromosome arms 12q (63%), 18q and 22q (37% each), as well as 1q, 9q, 11q, 12p, 16p and 17q (26% each). High-level amplifications were mapped to 9p23-p24 (1 tumor) and to 18q21-q23 (2 tumors). However, PCR-based analysis, Southern blot analysis and high-resolution matrix-CGH of the BCL2 gene revealed neither evidence for amplification nor for genetic rearrangement. Mutational analysis of BCL10 in 16 PCNSL identified four distinct sequence polymorphisms but no mutation. Taken together, our data do not support a role of BCL2 rearrangement/amplification and BCL10 mutation in PCNSL but indicate a number of novel chromosomal regions that likely carry yet unknown tumor suppressor genes or proto-oncogenes involved in the pathogenesis of these tumors.


Subject(s)
Central Nervous System Neoplasms/genetics , Chromosome Aberrations/genetics , Lymphoma, B-Cell/genetics , Lymphoma, Large B-Cell, Diffuse/genetics , Apoptosis Regulatory Proteins , Carrier Proteins/genetics , Female , Humans , Male , Middle Aged , Nucleic Acid Hybridization
4.
J Neuropathol Exp Neurol ; 58(10): 1041-50, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10515227

ABSTRACT

Oligodendroglial tumors frequently show allelic losses on the short arm of chromosome 1. To narrow down the putative tumor suppressor gene site(s) on 1p, we have investigated 35 oligodendrogliomas and 10 mixed gliomas (oligoastrocytomas) for loss of heterozygosity (LOH) at 21 highly polymorphic loci on chromosome 1 (19 loci on 1p and 2 loci on 1q). LOH at loci on 1p was found in 30 of the 45 tumors (67%). Two distinct regions of common allelic loss were identified: a distal region between D1S76 and D1S253 at 1p36.3, and a proximal region between D1S482 and D1S2743 at 1p34-p35. We also analyzed our tumor series for genetic alterations and expression of the cyclin dependent kinase inhibitor gene CDKN2C (p18INK4c) from 1p32. We found 1 recurrent anaplastic oligodendroglioma that carried a somatic CDKN2C mutation at codon 113 (GAA ==> TAA: Glu ==> Stop). The remaining 44 tumors of our series showed neither coding sequence mutations nor homozygous deletions of CDKN2C. Investigation of 35 tumors by differential reverse transcription-PCR revealed expression of CDKN2C transcripts in all instances. Our data thus provide evidence for more than a single oligodendroglioma-associated tumor suppressor gene on 1p and implicate CDKN2C as a candidate tumor suppressor gene altered in a low fraction of oligodendroglial tumors.


Subject(s)
Brain Neoplasms/genetics , Carrier Proteins/genetics , Cell Cycle Proteins , Chromosomes, Human, Pair 1/genetics , Enzyme Inhibitors , Gene Deletion , Glioma/genetics , Mutation/genetics , Oligodendroglioma/genetics , Tumor Suppressor Proteins , Adult , Aged , Alleles , Brain Neoplasms/pathology , Chromosome Mapping , Cyclin-Dependent Kinase Inhibitor p18 , Female , Glioma/pathology , Humans , Loss of Heterozygosity/genetics , Male , Middle Aged , Oligodendroglioma/pathology , RNA, Messenger/metabolism , Retrospective Studies , Reverse Transcriptase Polymerase Chain Reaction
5.
Brain Pathol ; 9(3): 435-42; discussion 432-3, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10416984

ABSTRACT

Malignant gliomas frequently show genetic aberrations of genes coding for cell cycle regulatory proteins involved in the control of G1/S phase transition. These include mutation and/or deletion of the retinoblastoma (RB1) gene, homozygous deletion of the CDKN2A and CDKN2B genes, as well as amplification and overexpression of the CDK4 and CDK6 genes. The D-type cyclins (cyclin D1, D2, and D3) promote cell cycle progression from G1 to S phase by binding to and activating the cyclin dependent kinases Cdk4 and Cdk6. Here, we have investigated a series of 110 primary malignant gliomas and 8 glioma cell lines for amplification and expression of the D-type cyclin genes CCND1 (11q13), CCND2 (12p13), and CCND3 (6p21). We found the CCND1 gene amplified and overexpressed in one anaplastic astrocytoma of our tumor series. Two glioblastomas and one anaplastic astrocytoma showed CCND2 gene amplification, but lacked significant overexpression of CCND2 transcripts. Amplification and overexpression of the CCND3 gene was detected in the glioblastoma cell line CCF-STTG1, as well as in one primary glioblastoma and in the sarcomatous component of one gliosarcoma. Our data thus suggest that amplification and increased expression of CCND1 and CCND3 contribute to the loss of cell cycle control in a small fraction of human malignant gliomas.


Subject(s)
Brain Neoplasms/genetics , Brain Neoplasms/metabolism , Cyclins/biosynthesis , Cyclins/genetics , Glioma/genetics , Glioma/metabolism , Blotting, Southern , Cell Cycle/genetics , Cyclin D , Cyclin D1/biosynthesis , Cyclin D1/genetics , Cyclin D2 , Cyclin D3 , Gene Amplification , Glioblastoma/genetics , Glioblastoma/metabolism , Gliosarcoma/genetics , Gliosarcoma/metabolism , Humans , Immunohistochemistry , Nucleic Acid Hybridization , Polymerase Chain Reaction
6.
Cancer Res ; 59(24): 6091-6, 1999 Dec 15.
Article in English | MEDLINE | ID: mdl-10626796

ABSTRACT

We have previously reported on the amplification and overexpression of the MDM2 proto-oncogene in a subset of malignant gliomas without TP53 mutation (G. Reifenberger et al, Cancer Res., 53: 2736-2739, 1993). Here, we show that the MDM4 (MDMX) gene located on 1q32 is a further target for amplification in malignant gliomas. MDM4 codes for a Mdm2-related protein that can bind to p53 and inhibits p53-mediated transcriptional transactivation. We investigated a series of 208 gliomas (106 glioblastomas, 46 anaplastic gliomas, and 56 low-grade gliomas) and identified 5 tumors (4 glioblastomas and 1 anaplastic oligodendroglioma) with MDM4 amplification and overexpression. Several other genes from 1q32 were found to be coamplified with MDM4, such as GAC1 in five tumors, REN in four tumors, and RBBP5 in three tumors. Additional analyses revealed that the malignant gliomas with MDM4 amplification and overexpression carried neither mutations in conserved regions of the TP53 gene nor amplification of the MDM2 gene. Taken together, our data indicate that amplification and overexpression of MDM4 is a novel molecular mechanism by which a small fraction of human malignant gliomas escapes p53-dependent growth control.


Subject(s)
Chromosomes, Human, Pair 1 , Glioma/genetics , Nuclear Proteins , Proto-Oncogene Proteins/genetics , Cell Division , Chromosome Mapping , Gene Amplification , Glioma/chemistry , Glioma/classification , Glioma/metabolism , Humans , Mutation , Proto-Oncogene Mas , Proto-Oncogene Proteins/biosynthesis , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-mdm2 , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism
7.
Nucleic Acids Res ; 26(4): 1056-62, 1998 Feb 15.
Article in English | MEDLINE | ID: mdl-9461468

ABSTRACT

The contiguous DNA sequence of a 60 kb genomic interval of barley chromosome 4HL has been assembled. The region harbours a single and novel gypsy -like retrotransposon, designated BAGY-1. Only three genes appear to reside in the genomic stretch. One predicts a plant homologue of ribophorin I, a subunit of the oligosaccharyltransferase-protein complex located in the rough endoplasmatic reticulum. The second is similar to the Drosophila g1 gene encoding a ring finger protein involved in developmental processes. The observed gene density is approximately 5-fold lower than in the best characterized dicot genome of Arabidopsis but 6- to 10-fold higher than expected from an equidistant gene distribution in the complex barley genome. Our data suggest that the 60 kb genomic interval represents part of a gene island, a seemingly distinctive feature of grass genomes.


Subject(s)
CpG Islands , DNA, Plant/genetics , Genome, Plant , Hordeum/genetics , Amino Acid Sequence , Animals , Arabidopsis/genetics , Base Composition , Drosophila/genetics , Gene Expression , Genes, Insect , Genes, Plant , Humans , Introns , Molecular Sequence Data , Retroelements , Species Specificity , Zea mays/genetics
8.
Genomics ; 44(1): 61-70, 1997 Aug 15.
Article in English | MEDLINE | ID: mdl-9286701

ABSTRACT

Resistance of barley (Hordeum vulgare) to the powdery mildew fungus Erysiphe graminis f.sp. hordei is conferred by several dominant genes, but also by recessive alleles of the Mlo locus mapping on the long arm of chromosome 4. In addition, this single-factor-mediated resistance is active against all known physiological races of the parasite. Thus the mechanism underlying mlo-mediated resistance should differ substantially from that mediated by the dominant genes. A positional cloning strategy to isolate the Mlo gene from the barley genome, the size of which is almost double the size of the human genome, has been designed. The AFLP technique was employed to identify markers tightly linked to the Mlo locus and to produce a local high-resolution genetic map. The use of this high-volume marker technology allowed the rapid screening of approximately 250,000 loci for linkage to Mlo. A large number of Mlo-linked AFLP markers were identified, one of which cosegregated with Mlo on the basis of more than 4000 meiotic events. A four-genome-equivalent barley YAC library (average insert size 480 kb) was constructed and screened with this cosegregating marker. Four YACs containing this marker were isolated and subsequent characterization by AFLP-based physical mapping allowed the physical delimitation of the Mlo locus to a DNA segment of 30 kb.


Subject(s)
Chromosome Mapping , Genes, Plant/genetics , Hordeum/genetics , Plant Proteins/genetics , Chromosomes/genetics , Chromosomes, Artificial, Yeast/genetics , Cloning, Molecular , DNA Fingerprinting , DNA Restriction Enzymes/metabolism , Fungi/pathogenicity , Gene Library , Genetic Linkage , Genetic Markers/genetics , Plant Diseases
9.
Cell ; 88(5): 695-705, 1997 Mar 07.
Article in English | MEDLINE | ID: mdl-9054509

ABSTRACT

Mutation-induced recessive alleles (mlo) of the barley Mlo locus confer a leaf lesion phenotype and broad spectrum resistance to the fungal pathogen, Erysiphe graminis f. sp. hordei. The gene has been isolated using a positional cloning approach. Analysis of 11 mutagen-induced mlo alleles revealed mutations leading in each case to alterations of the deduced Mlo wild-type amino acid sequence. Susceptible intragenic recombinants, isolated from mlo heteroallelic crosses, show restored Mlo wild-type sequences. The deduced 60 kDa protein is predicted to be membrane-anchored by at least six membrane-spanning helices. The findings are compatible with a dual negative control function of the Mlo protein in leaf cell death and in the onset of pathogen defense; absence of Mlo primes the responsiveness for the onset of multiple defense functions.


Subject(s)
Genes, Plant , Hordeum/genetics , Plant Proteins/genetics , Promoter Regions, Genetic/physiology , Amino Acid Sequence , Base Sequence , Blotting, Northern , Blotting, Southern , Cell Death/genetics , Chromosome Mapping , DNA, Plant/analysis , Gene Expression Regulation, Plant/genetics , Genetic Markers , Genotype , Hordeum/cytology , Hordeum/microbiology , Molecular Sequence Data , Mutation/physiology , Mycoplasma , Polymorphism, Restriction Fragment Length , RNA, Messenger/analysis , RNA, Plant/analysis , Recombinant Proteins
10.
J Pharm Biomed Anal ; 15(2): 201-20, 1996 Nov.
Article in English | MEDLINE | ID: mdl-8933422

ABSTRACT

(+)- and (-)-4-(6-methoxy-2-naphthyl)-2-butyl chloroformate (NAB-C) were prepared from the prochiral non-steroidal anti-inflammatory agent nabumetone with the aim of developing easily detectable chloroformate reagents for the enantiospecific HPLC analysis of amino compounds in biogenic matrices on achiral stationary phases. The new reagents were tested in the derivatization of beta-adrenoceptor antagonists and anti-arrhythmic agents and allowed derivatization in the presence of water. (+)- and (-)-NAB-C were compared with other reagents with a 6-methoxy-2-naphthyl moiety as a chromophore. The reagents were suitable for the analysis of nanogram amounts of, for example, metoprolol enantiomers in plasma, a prerequisite for application in pharmaco- or toxicokinetic studies.


Subject(s)
Adrenergic beta-Antagonists/blood , Anti-Inflammatory Agents, Non-Steroidal/chemistry , Biogenic Amines/analysis , Butanones/chemistry , Metoprolol/blood , Adult , Chromatography, High Pressure Liquid/methods , Humans , Indicators and Reagents , Male , Nabumetone , Stereoisomerism , Structure-Activity Relationship
11.
Yeast ; 10(4): 475-9, 1994 Apr.
Article in English | MEDLINE | ID: mdl-7941733

ABSTRACT

The strictly aerobic yeasts Candida pinus, Cryptococcus albidus, Rhodotorula minuta, Rhodotorula mucilaginosa and Trichosporon beigelii possess mitochondrial NADH dehydrogenases with significant features of the NADH:ubiquinone oxidoreductase (complex I). These species show in all growth phases and under standard cultivation conditions, NADH dehydrogenases of approximately 700 kDa, which are sensitive to rotenone, a specific inhibitor of this complex. Identical results were obtained with the weakly fermenting C. pinus. The facultatively fermenting yeasts Saccharomyces cerevisiae and Kluyveromyces marxianus do not possess the 700 kDa-complex and are insensitive to rotenone. In S. cerevisiae, a rotenone-insensitive NADH dehydrogenase of about 500-600 kDa is detected only in stationary phase cells. As in Neurospora crassa, upon incubation of the obligately aerobic yeast R. mucilaginosa with chloramphenicol, an intermediate NADH dehydrogenase of approximately 350 kDa was formed, which was insensitive to rotenone.


Subject(s)
Electron Transport , Fungal Proteins/metabolism , Mitochondria/enzymology , NADH, NADPH Oxidoreductases/metabolism , Quinone Reductases/metabolism , Yeasts/enzymology , Aerobiosis , Chloramphenicol/pharmacology , Electron Transport Complex I , Fermentation , Fungal Proteins/antagonists & inhibitors , NADH, NADPH Oxidoreductases/antagonists & inhibitors , Quinone Reductases/antagonists & inhibitors , Rotenone/pharmacology , Species Specificity , Yeasts/drug effects , Yeasts/growth & development
SELECTION OF CITATIONS
SEARCH DETAIL
...